IGF-I Lr3 is significantly more potent (2-3x) than IGF-I in studies, because it has a lower affinity to be rendered inactive by IGF binding proteins
The COMBO-DN study was a large, double-blind, randomized clinical trial that compared the efficacy and safety of high-dose monotherapy versus combination therapy with duloxetine and pregabalin in patients with DPN who had not responded to standard doses [126]
This stack is the choice when the goal is the maximum pulsatile GH output with a clean side-hormone profile and several injections per day are acceptable
GLP-1s are all the rage right now, in terms of reducing weight
Starting at 0.25mg for 2 weeks also gives you a clear baseline: did you feel anything
It gets labeled as anxiety, disorganization, or just being too much, and we carry that for years without realizing there might be more going on